Literature DB >> 15852762

Trends in laryngeal cancer incidence in Lithuania: a future perspective.

Lilija Jaseviciene1, Romualdas Gurevicius, Vytautas Obelenis, Saulius Cicenas, Algirdas Juozulynas.   

Abstract

OBJECTIVES: The aim of the present study was to assess the incidence of larynx cancer in Lithuania in the years 1978-2001 and to outline possible future trends.
MATERIALS AND METHODS: The number of new laryngeal cancer cases in 1978-2001 was obtained from the Lithuanian Cancer Registry. The Lithuanian Department of Statistics provided data on the population being at the same age in the same years. The data were adjusted for age, using the direct method in accordance with the European standard; a linear regression analysis of trends in the larynx cancer incidence was performed.
RESULTS: After standardization of data for the period of 1978-2001, an upward trend was registered for both men and women: in 1978 the incidence was 10.73 for men and 0.26 for women per 100000 population, in 2001 the corresponding data were 11.6 and 0.7. Throughout the study period the incidence was higher in men than in women and the mean age of male and female larynx cancer patients was increasing: mean age for men was annually increasing by 0.1566 years and for women by 0.0602 years. The forecast for men in 2006 is 13.88 and for women 0.54 cases per 100000 population.
CONCLUSIONS: The increase in larynx cancer incidence is growing more rapidly among women than among men, and the mean age of the patients is also increasing. The forecast is that in 2006 the incidence rate will be increasing, and both men and women will get ill at an older age.

Entities:  

Mesh:

Year:  2004        PMID: 15852762

Source DB:  PubMed          Journal:  Int J Occup Med Environ Health        ISSN: 1232-1087            Impact factor:   1.843


  8 in total

1.  Supracricoid partial laryngectomy cricohyoidoepiglottopexy (SCPL-CHEP) versus vertical partial laryngectomy for the treatment of glottic carcinoma.

Authors:  Si-Yi Zhang; Zhong-Ming Lu; Liang-Si Chen; Xiao-Ning Luo; Ping-Jiang Ge; Xin-Han Song; Shao-Hua Chen; Yi-Long Wu
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-16       Impact factor: 2.503

2.  Expression of Th1- Th2- and Th17-associated cytokines in laryngeal carcinoma.

Authors:  Xiaoqun Xu; Rui Wang; Qinghong Su; Haiyan Huang; Peng Zhou; Junwen Luan; Jingsheng Liu; Junfu Wang; Xuemei Chen
Journal:  Oncol Lett       Date:  2016-07-13       Impact factor: 2.967

3.  MicroRNA differential expression spectrum and microRNA-125a-5p inhibition of laryngeal cancer cell proliferation.

Authors:  Xiang-Dong Yao; Ping Li; Ji-Sheng Wang
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

4.  Evolution of the epidemiology and clinical characteristics of larynx and hypopharynx carcinoma in Poland from 1991 to 2001.

Authors:  Stanisław Bień; Bartłomiej Kamiński; Stanisław Zyłka; Ryszard Mezyk; Zdzisław Piasta
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-23       Impact factor: 2.503

5.  Does age influence disease-specific survival in patients with squamous cell carcinomas of the head and neck?

Authors:  Joan Lop; Cristina Valero; Jacinto García; Miquel Quer; Ian Ganly; Jatin P Shah; Snehal G Patel; Xavier León
Journal:  J Surg Oncol       Date:  2020-03-09       Impact factor: 3.454

6.  A preliminary study of the effect of ECRG4 overexpression on the proliferation and apoptosis of human laryngeal cancer cells and the underlying mechanisms.

Authors:  Jianping Jia; Song Dai; Xinghe Sun; Yuehong Sang; Zhenming Xu; Jie Zhang; Xiaofeng Cui; Jinhui Song; Xing Guo
Journal:  Mol Med Rep       Date:  2015-07-08       Impact factor: 2.952

7.  Micro-ribonucleic acid expression profiling and bioinformatic target gene analyses in laryngeal carcinoma.

Authors:  Zhong-Ming Lu; Ye-Feng Lin; Li Jiang; Liang-Si Chen; Xiao-Ning Luo; Xin-Han Song; Shao-Hua Chen; Si-Yi Zhang
Journal:  Onco Targets Ther       Date:  2014-04-05       Impact factor: 4.147

8.  miR-144-3p, a tumor suppressive microRNA targeting ETS-1 in laryngeal squamous cell carcinoma.

Authors:  Si-Yi Zhang; Zhong-Ming Lu; Ye-Feng Lin; Liang-Si Chen; Xiao-Ning Luo; Xin-Han Song; Shao-Hua Chen; Yi-Long Wu
Journal:  Oncotarget       Date:  2016-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.